Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
Keiichi Kondo, William Y Kim, Mirna Lechpammer et al. · 2003
Read Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth by Keiichi Kondo, William Y Kim, Mirna Lechpammer et al. (2003) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pbio-0000083.txt.
Description
Keiichi Kondo, William Y. Kim, Mirna Lechpammer, and their team reported a cancer finding in PLOS Biology in 2003. Some kidney tumors grow after the VHL gene is lost. That loss lets a protein called HIF2α build up and push tumor growth forward.
The authors asked a sharp question: is HIF2α the main driver, or just one of many? Their tests show that blocking HIF2α alone is enough to stop these tumors from growing. That narrows a complex pathway to one key target. For drug research, the message is direct. A treatment that lowers HIF2α action might help patients whose tumors lack working VHL.
Catalog record
| CREATOR | Keiichi Kondo, William Y Kim, Mirna Lechpammer et al. |
|---|---|
| YEAR | 2003 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pbio.0000083